Veloxis Pharmaceuticals
Presença
Asahi Kasei é uma das ...
Asahi Kasei é uma empresa listada sob o símbolo 3407 (JP).
Asahi Kasei tem presença direta em 10 países.Asahi Kasei possui 23 subsidiárias incluindo Asahi Kasei Construction, Asahi Kasei Homes e Asahi Kasei Medical.
Eles estão dentro:
- Equipamentos Médicos29%
- Produtos Químicos13%
- Outro58%
Executivos
Veja o organograma con seus 14 executivos principais
Biografias mais buscadas da Veloxis Pharmaceuticals
- Mark Hensley, Chief Executive Officer
- Ed Sleeper, Chief Ethics and Compliance Officer
- Ulf Meier-Kriesche, Chief Scientific Officer
Criar um alerta
para seguir os movimentos de executivos da Veloxis Pharmaceuticals.
Farmacêutica
Asahi Kasei possui 1.860 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Veloxis Pharmaceuticals
- News | Veloxis Pharmaceuticals Chief Scientific Officer to Receive National Kidney Foundation’s Market Innovation Award
- Transplant Therapeutics Consortium Receives Acceptance of Letter-of-Intent for iBox Scoring System as a Reasonably Likely Surrogate Endpoint from the Biomarker Qualification Program | Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark offentliggør det foreløbige resultat af samt afslutningen på dets offentlige købstilbud på aktier og warrants i Veloxis Pharmaceuticals | Veloxis Pharmaceuticals
- Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020 | Veloxis Pharmaceuticals
- Offentliggørelse af Nasdaq Copenhagen A/S' Accept af Veloxis Pharmaceuticals A/S' Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S | Veloxis Pharmaceuticals
- Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S | Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Konkurrencegodkendelser opnået for Asahi Kasei Pharma Denmarks offentlige overtagelsestilbud for aktier og warrants i Veloxis Pharmaceuticals | Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Påmindelse om deadline for accept af Asahi Kasei Pharma Denmarks offentlige overtagelsestilbud | Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Reminder of Approaching Deadline for the Acceptance of the Public Tender Offer by Asahi Kasei Pharma Denmark | Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals: Competition approvals obtained for the public tender offer by Asahi Kasei Pharma Denmark for the shares and warrants in Veloxis Pharmaceuticals | Veloxis Pharmaceuticals
- View more press releases Close
Redes sociais sobre Veloxis Pharmaceuticals
- Veloxis Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Veloxis Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Mark Hensley 
Ligue para a Veloxis Pharmaceuticals em +45 ...
